Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halogenated Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303089B details a mild Mn-mediated trifluoromethylation. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable room temperature processes.
Patent CN101381311A reveals a cost-effective nitration route for high-purity pharmaceutical intermediates, offering significant supply chain advantages.
Patent CN111004234A reveals a green ultrasonic halogenation method for imidazopyridines, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.